Login
Register
Submit a Paper
Propose a Special lssue
Open Access
RETRACTION
Retraction: miR-135a confers resistance to gefitinib in non-small cell lung cancer cells by upregulation of RAC1
Oncology Research 2025, 33(3), 733-733. https://doi.org/10.32604/or.2024.056906
Issue published 28 February 2025
This article is a retraction of:
miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1
Read original article
View Full Text
Download PDFAbstract
This article has no abstract.Cite This Article
APA Style
Oncology Research Editorial Office (2025). Retraction: miR-135a confers resistance to gefitinib in non-small cell lung cancer cells by upregulation of RAC1. Oncology Research, 33(3), 733–733. https://doi.org/10.32604/or.2024.056906
Vancouver Style
Oncology Research Editorial Office. Retraction: miR-135a confers resistance to gefitinib in non-small cell lung cancer cells by upregulation of RAC1. Oncol Res. 2025;33(3):733–733. https://doi.org/10.32604/or.2024.056906
IEEE Style
Oncology Research Editorial Office, “Retraction: miR-135a confers resistance to gefitinib in non-small cell lung cancer cells by upregulation of RAC1,” Oncol. Res., vol. 33, no. 3, pp. 733–733, 2025. https://doi.org/10.32604/or.2024.056906
Copyright © 2025 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
